The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

MIS18A  -  MIS18 kinetochore protein A

Homo sapiens

Synonyms: B28, C21orf45, C21orf46, FAPP1-associated protein 1, FASP1, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of C21orf45

 

High impact information on C21orf45

  • Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects [4].
  • OBJECTIVE: To evaluate the efficacy of the insulin analog lispro (Lys B28, Pro B29) in severe insulin resistance caused by human insulin antibodies [5].
  • Insulin's natural tendency to form dimers and hexamers is significantly reduced in a mutant insulin B28 Pro --> Asp, which has been designed as a monomeric, rapid-acting hormone for therapeutic purposes [6].
  • The structure of a cross-linked derivative of B28 Asp insulin, containing an Ala-Lys dipeptide linker between residues B30 Ala and A1 Gly, has also determined [6].
  • Two structures of B28 Asp insulin have been determined from crystals grown in the presence of phenol and m-cresol [6].
 

Biological context of C21orf45

  • An eight amino acid sequence, CAKGDWNC, from disintegrin barbourin, was introduced into an inactive human proinsulin molecule between the B28 and A2 sites to construct a chimeric, anti-thrombosis recombinant protein [7].
  • Pressure was applied at acupuncture points Gv4, Gv15, Gv20, B23, B28, B32, H7, H9, St36, Sp4, Sp6, Sp12, Ren2, Ren3, Ren6, K3 and K5 [8].
  • Other residues situated at the interface between the 2 monomers were found to make favorable but smaller contributions to the dimerization: Tyr B16, Val B12, and Pro B28, and to an even lesser extent, Gly B23 [9].
 

Anatomical context of C21orf45

  • Co-localization of pp5644 and FASP1 in cytoplasm in Hela cells could further support the interaction [10].
 

Associations of C21orf45 with chemical compounds

  • To determine the conformational properties of the C-terminal region of the insulin B-chain relative to the helical core of the molecule, we have investigated the fluorescence properties of an insulin analog in which amino acids B28 and B29 have been substituted with a tryptophan and proline residue respectively, ([WB28,PB29]insulin) [11].
  • Replacement of HB10 with aspartic acid increased stability while substitutions at B28 and/or B29 were either comparable to insulin or had decreased stability [12].
  • The natural sequence in human insulin at this position is proline at B28 and lysine at B29 [13].
 

Other interactions of C21orf45

  • The pp5644-interacting protein FAPP1 (phosphatidylinositol-four-phosphate adaptor protein1) associated protein-1, called FASP1, was obtained by using yeast two-hybrid system [10].
 

Analytical, diagnostic and therapeutic context of C21orf45

  • The interaction between pp5644 and FASP1 was experimentally confirmed by GST pull-down assay in vitro and co-immunoprecipitation assay in vivo [10].
  • In the antibacterial bioassay, the stems and the roots of H. capitellata showed moderate activity against the 4 tested bacteria while the leaves showed moderate activity towards B. subtilis B28, MRSA and P. aeruginosa only [14].

References

  1. Tyrosine phosphorylation of L1 family adhesion molecules: implication of the Eph kinase Cek5. Zisch, A.H., Stallcup, W.B., Chong, L.D., Dahlin-Huppe, K., Voshol, J., Schachner, M., Pasquale, E.B. J. Neurosci. Res. (1997) [Pubmed]
  2. A monoclonal antibody equivalent to anti-rat neural antigen-1 as a marker for Schwann cells. Fields, K.L., Dammerman, M. Neuroscience (1985) [Pubmed]
  3. Preclinical safety pharmacology studies on the rapid-acting insulin analogue insulin aspart. Dall, V. Arzneimittel-Forschung. (1999) [Pubmed]
  4. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Mudaliar, S.R., Lindberg, F.A., Joyce, M., Beerdsen, P., Strange, P., Lin, A., Henry, R.R. Diabetes Care (1999) [Pubmed]
  5. Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro. A case report. Lahtela, J.T., Knip, M., Paul, R., Antonen, J., Salmi, J. Diabetes Care (1997) [Pubmed]
  6. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 pro --> Asp insulin analogues. Whittingham, J.L., Edwards, D.J., Antson, A.A., Clarkson, J.M., Dodson, G.G. Biochemistry (1998) [Pubmed]
  7. Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence. Jing, J., Lu, S. Biotechnol. Lett. (2005) [Pubmed]
  8. Acupressure versus oxybutinin in the treatment of enuresis. Yuksek, M.S., Erdem, A.F., Atalay, C., Demirel, A. J. Int. Med. Res. (2003) [Pubmed]
  9. Study of the insulin dimerization: binding free energy calculations and per-residue free energy decomposition. Zoete, V., Meuwly, M., Karplus, M. Proteins (2005) [Pubmed]
  10. P5644 interacts with phosphatidylinositol-4-phosphate adaptor protein-1 associated protein-1. Ye, X.X., Lu, H., Yu, Y., Ding, N., Zhang, N.L., Huo, K.K., Wan, D.F., Li, Y.Y., Gu, J.R. Mol. Cell. Biochem. (2005) [Pubmed]
  11. Detection of an equilibrium intermediate in the folding of a monomeric insulin analog. Bryant, C., Strohl, M., Green, L.K., Long, H.B., Alter, L.A., Pekar, A.H., Chance, R.E., Brems, D.N. Biochemistry (1992) [Pubmed]
  12. Improved insulin stability through amino acid substitution. Brems, D.N., Brown, P.L., Bryant, C., Chance, R.E., Green, L.K., Long, H.B., Miller, A.A., Millican, R., Shields, J.E., Frank, B.H. Protein Eng. (1992) [Pubmed]
  13. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study. Tîrgovişte, C.I., Străchinariu, R., Farcaşiu, E., Milicevic, Z., Teodorescu, G. Romanian journal of internal medicine = Revue roumaine de médecine interne. (2003) [Pubmed]
  14. Antioxidant, radical-scavenging, anti-inflammatory, cytotoxic and antibacterial activities of methanolic extracts of some Hedyotis species. Ahmad, R., Ali, A.M., Israf, D.A., Ismail, N.H., Shaari, K., Lajis, N.H. Life Sci. (2005) [Pubmed]
 
WikiGenes - Universities